1-3 of 3
Jessica A. Cintolo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B25: Exosomal transcriptomic signatures tracks and predicts response to checkpoint blockade immunotherapy

Alvin Shi, Jessica A. Cintolo-Gonzalez, Isabel Chien, Dennis T. Frederick, Roman Alpatov, William Michaud, Deborah Plana, David Panka, Ryan Corcoran, Keith Flaherty, Ryan Sullivan, Manolis Kellis, Genevieve Boland
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): B25.
https://doi.org/10.1158/2326-6074.TUMIMM17-B25
Published: 01 September 2018
View article titled, Abstract B25: Exosomal transcriptomic signatures tracks and predicts response to checkpoint blockade immunotherapy
Journal Articles

Abstract A35: BRAF inhibition increases exosomal PD-L1 protein expression in melanoma

Gyulnara G. Kasumova, Alvin Shi, Jessica A. Cintolo-Gonzalez, Isabel Chein, Dennie T. Frederick, Roman Alpatov, William A. Michaud, Deborah Plana, David J. Panka, Ryan B. Corcoran, Keith T. Flaherty, Ryan J. Sullivan, Manolis Kellis, Genevieve M. Boland
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): A35.
https://doi.org/10.1158/2326-6074.TUMIMM17-A35
Published: 01 September 2018
View article titled, Abstract A35: BRAF inhibition increases exosomal PD-L1 protein expression in melanoma
Journal Articles

CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu–Expressing Cancers

Jashodeep Datta, Shuwen Xu, Cinthia Rosemblit, Jenessa B. Smith, Jessica A. Cintolo, Daniel J. Powell, Jr, Brian J. Czerniecki
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (5): 455–463.
https://doi.org/10.1158/2326-6066.CIR-14-0208
Published: 03 May 2015
View article titled, CD4<sup>+</sup> T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8<sup>+</sup> T-cell Targeting of HER2/<em>neu</em>–Expressing Cancers
Open the PDF for CD4<sup>+</sup> T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8<sup>+</sup> T-cell Targeting of HER2/<em>neu</em>–Expressing Cancers in another window
Includes: Supplementary data